Business Context and Reporting Period
Company: Alzamend Neuro, Inc. (ALZN)
Filing Type: Form 8-K (Current Report)
Date of Report: April 30, 2024
Reporting Period: Events occurring on April 29, 2024
This filing reports the entry into material definitive agreements and the creation of direct financial obligations. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transactions
This filing details specific financing activities rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction values include:
- Series B Preferred Stock Sale: Sold 100 shares of Series B Preferred Stock and warrants to purchase 100,000 shares of Common Stock to Ault Lending, LLC for $100,000.
- Cumulative Ault Lending Financing: As of April 29, 2024, Ault Lending has purchased an aggregate of 2,100 shares of Series B Preferred Stock and warrants for 2,100,000 shares for a total of $2.1 million. The total facility size is up to $6 million.
- Promissory Note Issuance: Issued a term note with a principal face amount of $310,000 to an accredited investor. The purchase price was $300,000 (reflecting an original issuance discount).
- Note Terms: Interest rate of 15% per annum; maturity date of May 13, 2024.
Material Changes and Agreements
The filing discloses the following material changes and agreements:
- Additional Closing with Affiliate: An additional closing occurred under the Securities Purchase Agreement with Ault Lending, LLC (an affiliate of the Company). The terms were previously disclosed in an 8-K filed on February 2, 2024.
- Short-Term Debt: The Company incurred a new short-term debt obligation maturing in approximately two weeks (May 13, 2024).
- Guaranty: Repayment of the $310,000 note is secured by a guaranty from Ault Lending and Milton C. Ault (Vice Chairman of the Company and CEO of Ault Alliance, Inc.).
- Unregistered Sales: The Series B Preferred Stock and Warrants were sold in reliance on the Section 4(a)(2) exemption from registration.
Guidance, Risks, and Contingencies
Management Commentary and Outlook: The filing does not contain forward-looking guidance, revenue projections, or management commentary regarding future business operations beyond the execution of these financing agreements.
Risks and Contingencies:
- Liquidity Timing: The Company has a significant short-term liability ($310,000 principal) due on May 13, 2024, creating immediate liquidity pressure.
- Affiliate Transactions: Financing is heavily reliant on an affiliate (Ault Lending), which may indicate limited access to broader capital markets.
- Default Risk: The Promissory Note contains standard events of default for failure to make payments when due.
Investor Verification Checklist
- Verify the Company's ability to repay the $310,000 note principal by the May 13, 2024 maturity date.
- Review the February 2, 2024 Form 8-K to understand the full terms of the $6 million facility with Ault Lending.
- Confirm the status of the Company's cash position and whether additional capital raises are planned to meet the upcoming debt obligation.
- Assess the extent of Milton C. Ault's and Ault Lending's involvement in the Company's capital structure.